Company History
Novacor® LVAS
WorldHeart's Novacor® LVAS is an implanted, wearable system that provides long-term pulsatile circulatory support for patients with life-threatening heart failure. Since 1984, the Novacor® LVAS has been implanted in more than 1,800 patients, predominantly for a Bridge-To-Transplant indication. Sales of the Novacor LVAS were discontinued in 2008.
The field experience and expertise gained by clinical use and commercial sale of the Novacor LVAS in North America, Europe and Japan has been applied to the development of WorldHeart's next-generation rotary blood pumps: Levacor VAD, MIVAD and the PediaFlow VAD.
Pioneering Reliability
In the nearly 100 medical centers worldwide that have used the Novacor® LVAS, it is renowned for its reliability and durability. Of the more than 1,800 Novacor® LVAS recipients to date supported for a cumulative period of more than 800 years, several hundred have been supported for multiple years. It is the first mechanical circulatory support device to support a single patient for more than six years, a record that still stands today for an implantable pulsatile pump.
Please browse this section for information about How Novacor® LVAS Works, Novacor LVAS Product Enhancements made and introduced during its clinical use, and the Novacor manual available for download.